- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04336475
The Effect of a Home-based Orofacial Exercise Program on Oral Aperture of Systemic Sclerosis Patients
April 16, 2020 updated by: Nihan Cüzdan, Cukurova University
The Effect of a Combined Home-based Orofacial Exercise Program on Oral Aperture of Patients With Systemic Sclerosis: a Single-blind Prospective Randomized Controlled Trial
Systemic sclerosis is a systemic disease which may involve multiple organ systems and cause functional disabilities.
Microstomia is one of the most common complications of the disease which may result in difficulties performing oral self-care, complication in professional dental care and even malnutrition in the advanced cases.
Since the disease is rare and the studies are limited, there is still not an agreed upon orofacial exercise program to improve the oral aperture of the patients.
Therefore, we aimed to investigate the effect of a newly diseased home-based exercise program for improving microstomia in those patient population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study was designed as a single-blind, prospective, randomized controlled study with a 2-month follow-up period, carried out in rheumatology outpatient clinic, between March 2017 - January 2019.
Systemic sclerosis patients with an oral aperture of <40mm were included in the study.
Patients were randomly divided into two groups.
Randomization was done as the sealed envelope method.
After the informed consent was taken, the opaque envelope that the patient have chosen was opened and patients were offered the allocated treatment regimen.
Group 1 was given exercise regimen and oral hygiene care advices for the first one month; followed by no exercise but oral hygiene care advices for the next four weeks.
Group 2, as the control group, received oral hygiene care advices for the first one month, followed by the exercise regimen twice a day along with oral hygiene care advices for the next four weeks.
Oral care advices were given to every participant by a dentist involved in the study at their first visit.
With this protocol, we aimed (a) to investigate whether there is a benefit of the exercise program on microstomia; (b) to observe the carryover effect of exercise therapy on microstomia after discontinuing the treatment over a period of time; (c) to estimate the intervention strategy by comparing the same medical approach with different sequences.
The exercise program was demonstrated to patients by a clinician at the first visit and given to all patients printed as a manual to be done every day for one month duration of the exercise program.
Additionally, a diary was given to patients to mark when they have completed the exercise and to note in the case of pain on daily basis.
The exercise regimen was developed on the basis of previous studies and clinical knowledge.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Adana, Turkey, 01030
- Cukurova University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
* systemic sclerosis patients with an interincisal distance of <40 mm
Exclusion Criteria:
- patients with missing teeth
- dysfunction of temporo-mandibular joints
- oral malignancy
- recent dental procedures
- multiple active digital ulcers
- diagnosed psychiatric conditions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Group 1
exercise regimen and oral hygiene care advices
|
combined stretching&strengthening exercise regimen
|
Active Comparator: Group 2
oral hygiene care advices
|
combined stretching&strengthening exercise regimen
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change From Baseline in Oral Aperture Measurement
Time Frame: 2 months
|
the interincisal distance between the maxillary and mandibular central incisors in the midline
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nihan Cuzdan, MD, MD
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2017
Primary Completion (Actual)
January 31, 2019
Study Completion (Actual)
January 31, 2019
Study Registration Dates
First Submitted
April 3, 2020
First Submitted That Met QC Criteria
April 3, 2020
First Posted (Actual)
April 7, 2020
Study Record Updates
Last Update Posted (Actual)
April 29, 2020
Last Update Submitted That Met QC Criteria
April 16, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cukurova University Nihan C.
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Yes
IPD Plan Description
all collected IPD may be shared with other researches.
IPD Sharing Time Frame
up to 6 months
IPD Sharing Access Criteria
researchers who are willing to access to individual participant data will be reviewed and approved by the principal investigator.
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Sclerosis
-
Horizon Pharma Ireland, Ltd., Dublin IrelandEnrolling by invitationDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicKorea, Republic of, France, United States, Spain, Mexico, Japan, Argentina, Greece, Israel
-
Horizon Therapeutics Ireland DACRecruitingDiffuse Cutaneous Systemic Sclerosis | Sclerosis, SystemicNetherlands, Spain, Germany, United States, Japan, France, Italy, Korea, Republic of, Portugal, Israel, Greece, Argentina, Austria, Mexico, Poland, Switzerland, United Kingdom, Romania, Chile
-
Michael M. PhamTerminatedSystemic Sclerosis | Scleroderma, Systemic | Scleroderma, Diffuse | Diffuse Cutaneous Systemic Sclerosis | Interstitial Lung Disease | Scleroderma | Systemic Sclerosis, Diffuse | Diffuse Systemic Sclerosis | Pulmonary Fibrosis Interstitial | Diffuse Scleroderma | Diffuse Cutaneous Scleroderma | Progressive Systemic... and other conditionsUnited States
-
University of ManchesterCompletedEarly Diffuse Cutaneous Systemic Sclerosis
-
Fred Hutchinson Cancer CenterNational Institute of Allergy and Infectious Diseases (NIAID)CompletedSystemic Scleroderma | Severe Systemic SclerosisUnited States
-
Kadmon, a Sanofi CompanyTerminatedDiffuse Cutaneous Systemic Sclerosis | System; SclerosisUnited States
-
Boston UniversityCompleted
-
Federal University of São PauloUnknown
-
Lawson Health Research InstituteMallinckrodtNot yet recruitingDiffuse Cutaneous Systemic SclerosisCanada
-
Mitsubishi Tanabe Pharma America Inc.CompletedDiffuse Cutaneous Systemic SclerosisSpain, Belgium, United States, United Kingdom, Poland, Canada, Germany, Italy
Clinical Trials on orofacial exercise program
-
Hasan Kalyoncu UniversityCompletedTemporomandibular Disorders | Dysphagia, Oral PhaseTurkey
-
Marmara UniversityRecruitingTemporomandibular Joint Disorders | Temporomandibular DisorderTurkey
-
Umeå UniversityUppsala UniversityCompleted
-
University of Sao PauloCompletedTemporomandibular DisordersBrazil
-
Azienda Sanitaria Locale CN1 CuneoNot yet recruiting
-
Universidad de GranadaRecruiting
-
University of MiamiRecruiting
-
Riphah International UniversityCompletedSports Physical Therapy | Sports InjuryPakistan
-
Marmara UniversityCompletedCervical Disc HerniationTurkey
-
Marius HenriksenCompletedPatellofemoral Pain SyndromeDenmark